Navigation Links
Mediware's Transfusion Management Software Adopted by Four Additional Tenet Hospitals

LENEXA, Kan., Oct. 22 /PRNewswire-FirstCall/ -- Mediware Information Systems (Nasdaq: MEDW) announced today that four additional hospitals in the Tenet Healthcare system have licensed Mediware's HCLL(TM) Transfusion Management software system, which provides automated support for highly regulated blood processes to reduce transfusion errors, improve patient safety and maximize operational efficiency.

Tenet Healthcare Corporation (NYSE: THC) is based in Dallas, Texas, and through its subsidiaries, owns and operates 66 acute care hospitals in 12 states. Several have earned national quality awards. To date, nine Tenet hospitals have entered into agreements with Mediware. The four newest HCLL adopters are: Frye Regional Medical Center, Hickory, NC; Spalding Regional Medical Center, Griffin, Ga. and Cypress Fairbanks Medical Center and Houston Northwest Medical Center in Houston Tex.

According to John Damgaard, chief operating officer of Mediware, more than 300 top-tier healthcare institutions have licensed HCLL since the product was commercially released. From donor to recipient, HCLL is designed to manage blood products administered at hospitals and centralized transfusion service facilities. It is a powerful software tool for reducing transfusion errors, enhancing patient safety, managing the hospital's blood supply and maximizing the efficiency and productivity of the entire transfusion process.

"With more and more products in blood-bank inventories, there is a critical need for clear, clinically relevant and reportable information communicated in a closed loop," said Damgaard. "Blood products are highly regulated products but detailed data isn't available in all environments. Major health systems like Tenet rely on HCLL to capture, manage and track this information so transfusions are safe and efficient."

Damgaard added that HCLL's strong market acceptance is based on its rich functionality, enterprise-level features and utilities, and advanced integration capabilities. "HCLL gives multi-facility health systems like Tenet Healthcare the ability to manage blood services processes from its central location," said Damgaard.

For Cypress and Spalding, HCLL solved the need to automate the manual and potentially error-prone process of making bar-coded labels for blood products, now mandated by guidelines from the International Society for Blood Transfusion, known as ISBT 128. HCLL combines label production and product verification in one step.

Frye and Houston Northwest are users of Mediware's legacy Lifeline product and are upgrading to HCLL.

Mediware is demonstrating the effectiveness of the HCLL suite at the American Association of Blood Banks meeting in Anaheim, CA, This includes the company's newest offering, BloodSafe, which enables hospital blood banks to securely store blood products in high need hospital wards. More information on ClosedLoop(TM) blood management can be obtained from

About Mediware

Mediware delivers blood and medication management software systems that encapsulate information supporting patient therapies, reinforce patient safety practices and improve efficiencies to lower costs. Mediware's customers include prestigious hospitals, clinics, correctional institutions, blood centers and other public and private health care institutions throughout the world. For more information about Mediware products and services, visit our web site at

About HCLL(TM)

The HCLL suite of products, including HCLL Transfusion and HCLL Donor, provide healthcare facilities with powerful technology and rich clinical functionality necessary to streamline blood management processes -- from donation to transfusion. Blood bank management software products are classified by the FDA as medical devices and require 510(k) clearance.

Certain statements in this press release may constitute "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, as the same may be amended from time to time (the "Act") and in releases made by the SEC from time to time. Such forward-looking statements are not based on historical facts and involve known and unknown risks, uncertainties and other factors disclosed in the Company's Annual Report on Form 10-K for the year ended June 30, 2007, which may cause the actual results of the Company to be materially different from any future results expressed or implied by such forward-looking statements. The Company disclaims any obligation to update its forward-looking statements.

SOURCE Mediware Information Systems
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Blood transfusions beneficial after heart attacks
2. Blood transfusion linked to lung ailment
3. Alternative to blood Transfusions
4. Need for Blood Transfusions reduced
5. West Nile and Blood Transfusions
6. Mad Cow Disease Might Be Linked to Blood Transfusions
7. Blood Transfusion A Likely Cause For A Rare And Fatal Brain Disorder
8. Blood Transfusion May Not Be Required For Thalassaemia
9. Hepatitis C Virus To Be Screened Before Blood Transfusion
10. Blood Transfusion May Have Contributed Towards Hepatitis C
11. Kerr Discourages Transfusion Hepatitis Inquiry
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... December 1, 2015 -- ... the company’s growing product line of food safety and seafood fraud prevention tools. ... nerka) – allow InstantLabs to offer fast, reliable species identification for the four ...
(Date:12/1/2015)... ... 01, 2015 , ... It’s official: Tattoo taboo is a thing of the ... among Millennials (a whopping one in three aged 18 to 25 is inked). As ... with their ink. In fact, RealSelf , the world’s largest community for learning ...
(Date:12/1/2015)... ... December 01, 2015 , ... The importance of volumetric ... the focus of numerous abstracts accepted for presentation here, at the 101st Annual ... abstracts highlight the use of Volpara Solutions’ quantitative breast imaging software tools for ...
(Date:12/1/2015)... CA (PRWEB) , ... December 01, 2015 , ... ... scale , Visage Imaging Inc. (“Visage”), a wholly owned subsidiary of Pro Medicus ... imaging results enhancements at the Radiological Society of North America (RSNA) 2015 annual ...
(Date:12/1/2015)... ... December 01, 2015 , ... McLean, VA., December 1, ... fixed price per sprint agile development contract to support the National Geospatial-Intelligence Agency's ... years, provides software engineering, infrastructure, as well as operations and sustainment support to ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , Dec. 1, 2015 Relmada Therapeutics, Inc. (OTCQB: ... of chronic pain, announced today that the company will present ... held December 1-3 at the Luxe Sunset Boulevard Hotel in ... , CEO of Relmada Therapeutics, will present on Thursday, December ... . Please register at least 10 minutes ...
(Date:12/1/2015)... ANGELES , Dec. 1, 2015 CytRx ... development company specializing in oncology, today announced that it ... the company,s pivotal global Phase 3 clinical trial of ... (STS). Enrollment was originally estimated to be completed in Q1 ... being conducted under a Special Protocol Assessment from the ...
(Date:12/1/2015)... CHESTERBROOK, Pa. , Dec. 1, 2015 /PRNewswire/ ... leader, announced the launch of CareFront, a first-of-its-kind ... of patients diagnosed with cancer. Designed to be ... newly diagnosed cancer patients with resources for their ... costs. The program also offers tools to help ...
Breaking Medicine Technology: